Morphine Sulfate Injection 2 mg/mL Prefilled Syringes
Fresenius Kabi recalls Morphine Sulfate 2 mg/mL syringes over a label mixup that may contain Dilaudid.
Consumers and healthcare providers should immediately stop using the recalled syringes, quarantine them, and contact Fresenius Kabi for return and replacement instructions.
Recall at a glance
- Quantity recalled
- 625500 syringes
Why it was recalled
Fresenius Kabi is recalling Morphine Sulfate Injection, USP, 2 mg/1 mL, 1 mL single-dose Simplist prefilled syringes because a syringe labeled as Morphine may actually contain Dilaudid 0.5 mg/0.5 mL. This label mixup poses a serious risk of opioid overdose or underdose for patients.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Tyenne® (tocilizumab-aazg) Injection, 400 mg 20 mL (20mg mL) 20 mL vial
- Lot code
- 16UI07
- Best-by
- 08/2028
- NDC
- 65219-594-20
- First Ship Date
- 03 03 2026
- Last Ship Date
- 03 25 2026
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Labeling Error recalls
Other recent recalls from Fresenius Kabi USA, LLC
Editorial summary by Recall Canary · summary updated 2026-08-28 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification